Genedrive launches £8m equity raising to fund Covid-19 test

Tue, 5th May 2020

Molecular diagnostics company Genedrive launched a £8m share issue to fund the development of a Covid-19 test. New shares in the company were being offered at 80p each, via a £7m placing and £1m broker option. Genedrive said proceeds would support the rapid development of SARS-CoV-2 assays and development of a SARS-CoV-2 test. SARS-CoV-2 is the virus that causes the Covid-19 disease. At 1:16pm: (LON:GDR) Genedrive Plc share price was -0.5p at 197.5p Story provided by

FTSE 100 Latest